(NHI) National Health Investors - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US63633D1046
NHI EPS (Earnings per Share)
NHI Revenue
NHI: Senior, Housing, Healthcare, Financing, Investments
National Health Investors Inc (NYSE: NHI) is a real estate investment trust that has been operating since 1991, focusing on senior housing and medical investments through various financial structures such as sale-leasebacks, joint ventures, and mortgage financing. The companys diverse portfolio includes independent living, assisted living, and memory care communities, as well as skilled nursing facilities and specialty hospitals, catering to the growing demand for senior care services.
With a strong presence in the healthcare REIT sector, NHI has established itself as a significant player, providing need-driven and discretionary senior housing and medical investments. The companys business model is designed to generate stable income through rental payments, interest on loans, and other investment returns, making it an attractive option for investors seeking exposure to the healthcare real estate market.
Analyzing the current market data, NHIs stock price is currently at $71.84, slightly below its short-term moving averages (SMA20: $72.93, SMA50: $73.81), indicating a potential buying opportunity. The stocks ATR of 1.51 represents a 2.10% daily price range, suggesting moderate volatility. Considering the 52-week high and low prices ($82.14 and $61.42, respectively), the stock is currently trading near the lower end of its recent price range.
Combining the technical and fundamental data, a forecast for NHI can be derived. With a market capitalization of $3.385 billion and a forward P/E ratio of 12.84, the stock appears to be undervalued relative to its earnings potential. Additionally, the companys return on equity (RoE) of 10.72% indicates a stable and profitable business model. Based on these factors, a potential price target for NHI could be around $80-$85, representing a 11-18% upside from current levels, driven by the companys strong fundamentals and the growing demand for senior housing and medical investments.
As the senior population continues to grow, NHI is well-positioned to benefit from this trend, with its diversified portfolio and flexible business model. Investors seeking exposure to the healthcare REIT sector may consider NHI as a viable option, given its stable income generation and potential for long-term growth.
Additional Sources for NHI Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
NHI Stock Overview
Market Cap in USD | 3,312m |
Sector | Real Estate |
Industry | REIT - Healthcare Facilities |
GiC Sub-Industry | Health Care REITs |
IPO / Inception | 1991-10-09 |
NHI Stock Ratings
Growth Rating | 35.9 |
Fundamental | 37.1 |
Dividend Rating | 45.8 |
Rel. Strength | -1 |
Analysts | 3.88 of 5 |
Fair Price Momentum | 72.44 USD |
Fair Price DCF | 96.18 USD |
NHI Dividends
Dividend Yield 12m | 6.28% |
Yield on Cost 5y | 10.29% |
Annual Growth 5y | -3.99% |
Payout Consistency | 93.8% |
Payout Ratio | 119.3% |
NHI Growth Ratios
Growth Correlation 3m | -32.4% |
Growth Correlation 12m | -1.5% |
Growth Correlation 5y | 55.6% |
CAGR 5y | 10.09% |
CAGR/Max DD 5y | 0.32 |
Sharpe Ratio 12m | 1.00 |
Alpha | 5.29 |
Beta | 0.370 |
Volatility | 22.53% |
Current Volume | 588.3k |
Average Volume 20d | 285k |
As of June 21, 2025, the stock is trading at USD 70.77 with a total of 588,310 shares traded.
Over the past week, the price has changed by -0.23%, over one month by -5.30%, over three months by -4.17% and over the past year by +11.65%.
Partly, yes. Based on ValueRay´s Fundamental Analyses, National Health Investors (NYSE:NHI) is currently (June 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 37.10 and therefor a somewhat positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of NHI is around 72.44 USD . This means that NHI is currently overvalued and has a potential downside of 2.36%.
National Health Investors has received a consensus analysts rating of 3.88. Therefor, it is recommend to buy NHI.
- Strong Buy: 3
- Buy: 1
- Hold: 4
- Sell: 0
- Strong Sell: 0
According to our own proprietary Forecast Model, NHI National Health Investors will be worth about 78.2 in June 2026. The stock is currently trading at 70.77. This means that the stock has a potential upside of +10.54%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 80.9 | 14.3% |
Analysts Target Price | 80.7 | 14% |
ValueRay Target Price | 78.2 | 10.5% |